Asymmetric dimethylarginine

An endogenous NOS inhibitor

此产品仅用于科学研究，我们不为任何个人用途提供产品和服务

库存: 现货

可选规格

包装

价格

促销价

数量
5mg

￥637.00

510.00

- +
25mg

￥2037.00

1630.00

- +

已选 0 种 0 瓶

金额: ￥0.00

首页收藏

货号: ajce49156
CAS: 30315-93-6
别名: N5-[(二甲基氨基)亚氨基甲基]-L-鸟氨酸
分子式: C8H18N4O2
分子量: 202.25
纯度: >98%
溶解度: Water : 150 mg/mL (741.66 mM);Water : 100 mg/mL (494.44 mM)
储存: Store at -20°C, stored under nitrogen
库存: 现货

Background

N^G,N^G-dimethyl-L-arginine (ADMA) is an endogenous inhibitor of nitric oxide synthase (NOS).^1,2 It is formed from arginine by protein arginine methyltransferases (PRMTs) and degraded by dimethylarginine dimethylaminohydrolases (DDAHs) and alanine-glyoxylate aminotransferase 2 (AGXT2).¹ ADMA levels are increased concomitant with an increase in blood pressure in Dahl salt-sensitive rats fed a high-salt diet.² ADMA levels are increased in the plasma in a variety of endothelial dysfunction-related diseases, including hypertension, congestive heart failure, and end-stage renal disease.^1,3,4

1.Sydow, K., and Münzel, T.ADMA and oxidative stressAtheroscler. Suppl.4(4)41-51(2003) 2.Jin, J.S., and D'Alecy, L.G.Central and peripheral effects of asymmetric dimethylarginine, an endogenous nitric oxide synthetase inhibitorJ. Cardiovasc. Pharmacol.28(3)439-446(1996) 3.Vallance, P., Leone, A., Calver, A., et al.Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failureLancet339(8793)572-575(1992) 4.Matsuoka, H., Itoh, S., Kimoto, M., et al.Asymmetrical dimethylarginine, an endogenous nitric oxide synthase inhibitor, in experimental hypertensionHypertension29(1 Pt 2)242-247(1997)